No abstract available
Keywords:
Clinical decision-making; Hepatitis B; Mass screening; Public health.
MeSH terms
-
Adult
-
Aged
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / economics
-
Antiviral Agents / therapeutic use
-
Australia / epidemiology
-
Cost of Illness
-
Cost-Benefit Analysis
-
Fibrosis / economics
-
Fibrosis / epidemiology
-
Fibrosis / prevention & control
-
Health Services Accessibility / legislation & jurisprudence*
-
Health Services Accessibility / standards
-
Hepatitis B / diagnosis*
-
Hepatitis B / epidemiology
-
Hepatitis B / prevention & control
-
Hepatitis B Vaccines / administration & dosage
-
Hepatitis B Vaccines / therapeutic use
-
Humans
-
Liver Neoplasms / economics
-
Liver Neoplasms / epidemiology
-
Liver Neoplasms / prevention & control
-
Mass Screening / methods*
-
Mass Screening / standards
-
Mass Screening / statistics & numerical data
-
Middle Aged
-
Practice Guidelines as Topic
-
Prevalence
Substances
-
Antiviral Agents
-
Hepatitis B Vaccines